1
|
Macintyre F, Ramachandruni H, Burrows JN, Holm R, Thomas A, Möhrle JJ, Duparc S, Hooft van Huijsduijnen R, Greenwood B, Gutteridge WE, Wells TNC, Kaszubska W. Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria. Malar J 2018; 17:402. [PMID: 30384848 PMCID: PMC6211409 DOI: 10.1186/s12936-018-2549-1] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2018] [Accepted: 10/24/2018] [Indexed: 12/20/2022] Open
Abstract
Over the last 15 years, the majority of malaria drug discovery and development efforts have focused on new molecules and regimens to treat patients with uncomplicated or severe disease. In addition, a number of new molecular scaffolds have been discovered which block the replication of the parasite in the liver, offering the possibility of new tools for oral prophylaxis or chemoprotection, potentially with once-weekly dosing. However, an intervention which requires less frequent administration than this would be a key tool for the control and elimination of malaria. Recent progress in HIV drug discovery has shown that small molecules can be formulated for injections as native molecules or pro-drugs which provide protection for at least 2 months. Advances in antibody engineering offer an alternative approach whereby a single injection could potentially provide protection for several months. Building on earlier profiles for uncomplicated and severe malaria, a target product profile is proposed here for an injectable medicine providing long-term protection from this disease. As with all of such profiles, factors such as efficacy, cost, safety and tolerability are key, but with the changing disease landscape in Africa, new clinical and regulatory approaches are required to develop prophylactic/chemoprotective medicines. An overall framework for these approaches is suggested here.
Collapse
Affiliation(s)
- Fiona Macintyre
- Medicines for Malaria Venture, Route de Pré Bois 20, 1215, Geneva, Switzerland
| | - Hanu Ramachandruni
- Medicines for Malaria Venture, Route de Pré Bois 20, 1215, Geneva, Switzerland
| | - Jeremy N Burrows
- Medicines for Malaria Venture, Route de Pré Bois 20, 1215, Geneva, Switzerland
| | - René Holm
- Drug Product Development, Janssen R&D, Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.,Department of Science and Environment, Roskilde University, 4000, Roskilde, Denmark
| | - Anna Thomas
- Medicines for Malaria Venture, Route de Pré Bois 20, 1215, Geneva, Switzerland
| | - Jörg J Möhrle
- Medicines for Malaria Venture, Route de Pré Bois 20, 1215, Geneva, Switzerland
| | - Stephan Duparc
- Medicines for Malaria Venture, Route de Pré Bois 20, 1215, Geneva, Switzerland
| | | | - Brian Greenwood
- Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
| | | | - Timothy N C Wells
- Medicines for Malaria Venture, Route de Pré Bois 20, 1215, Geneva, Switzerland.
| | - Wiweka Kaszubska
- Medicines for Malaria Venture, Route de Pré Bois 20, 1215, Geneva, Switzerland
| |
Collapse
|
6
|
Chi KH, Danavall D, Taleo F, Pillay A, Ye T, Nachamkin E, Kool JL, Fegan D, Asiedu K, Vestergaard LS, Ballard RC, Chen CY. Molecular differentiation of Treponema pallidum subspecies in skin ulceration clinically suspected as yaws in Vanuatu using real-time multiplex PCR and serological methods. Am J Trop Med Hyg 2014; 92:134-8. [PMID: 25404075 DOI: 10.4269/ajtmh.14-0459] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
We developed a TaqMan-based real-time quadriplex polymerase chain reaction (PCR) to simultaneously detect Treponema pallidum subspecies pallidum, T. pallidum subsp. pertenue, and T. pallidum subsp. endemicum, the causative agents of venereal syphilis, yaws, and bejel, respectively. The PCR assay was applied to samples from skin ulcerations of clinically presumptive yaws cases among children on Tanna Island, Vanuatu. Another real-time triplex PCR was used to screen for the point mutations in the 23S rRNA genes that have previously been associated with azithromycin resistance in T. pallidum subsp. pallidum strains. Seropositivity by the classical syphilis serological tests was 35.5% among children with skin ulcerations clinically suspected with yaws, whereas the presence of T. pallidum subsp. pertenue DNA was only found in lesions from 15.5% of children. No evidence of T. pallidum subsp. pertenue infection, by either PCR or serology was found in ∼59% of cases indicating alternative causes of yaws-like lesions in this endemic area.
Collapse
Affiliation(s)
- Kai-Hua Chi
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - Damien Danavall
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - Fasihah Taleo
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - Allan Pillay
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - Tun Ye
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - Eli Nachamkin
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - Jacob L Kool
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - David Fegan
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - Kingsley Asiedu
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - Lasse S Vestergaard
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - Ronald C Ballard
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| | - Cheng-Yen Chen
- Laboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention, Atlanta, Georgia; Centers for Disease Control and Prevention, Atlanta, Georgia; Ministry of Health, Port Vila, Vanuatu; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; World Health Organization, Port Vila, Vanuatu; World Health Organization Consultant, Springhill, Brisbane, Australia; Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; World Health Organization, Western Pacific Regional Office, Manila, Philippines
| |
Collapse
|